Similarly, the prevalence of declined eGFR increased from 41.4% to 53.9% (p for trend <0.001) while that of CKD increased from 0.3% to 3.3% (p for trend <0.001) with increasing FSH quartiles (Figure 2 and Table 2). Here, BRD2 is linked to chronic kidney disease.